Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Astellas
Pharma
Regor, Legend, WuXi—Fierce Pharma Asia
Roche splashed considerable upfront cash in its Regor deal. Legend Biotech's momentum continued with a pair of developments this week. And more.
Eric Sagonowsky
Oct 4, 2024 8:20am
J&J's Erleada shows survival edge over Xtandi in real-world study
Oct 2, 2024 2:42pm
Astellas cruises into first DTC campaign for GA med Izervay
Sep 30, 2024 4:00pm
Gilead leads Asian patient groups' drugmaker reputation rankings
Sep 25, 2024 10:40am
Daiichi, Eisai, Granules—Fierce Pharma Asia
Sep 20, 2024 10:16am
Astellas, AstraZeneca, Glenmark and more—Fierce Pharma Asia
Sep 6, 2024 9:00am
